<DOC>
	<DOCNO>NCT00356772</DOCNO>
	<brief_summary>To evaluate azithromycin ocular conjunctiva concentration 7 14 day treatment initiation . To assess ocular systemic tolerance/safety azithromycin tear concentration Day 7</brief_summary>
	<brief_title>Azithromycin Level Tears Conjunctiva 36 Healthy Volunteers</brief_title>
	<detailed_description>The aim present study compare azithromycin tear conjunctival ocular concentration one instillation T1225 1.5 % eye drop , twice day one day versus one instillation T1225 1.5 % eye drop , twice day 3 day versus oral single dose 1g azithromycin .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Eye Infections , Bacterial</mesh_term>
	<criteria>Written inform consent ; Healthy volunteer ; Registered national register healthy volunteer ; Male female age 18 45 year old ; Able understand study instruction ; Likely comply study schedule treatment ; Normal subjective ocular symptom , Schirmer test &gt; 10 mm 5 min correct visual acuity &gt; = 6/10 eye Ocular trauma , infection inflammation within last 3 month ; Blepharitis ; Conjunctival hyperaemia ( score &gt; = 2 ) ; Fluoresceinstained punctuation ( score &gt; = 1b ) ; Hypersensitivity one product use study ; Clinically relevant allergy ; Medical surgical history incompatible study ; Recent acute illness ; Ocular surgery , include LASIK , LASEK PRK within last 12 month ; Other ocular laser Zithromax® Azadose® within last 3 month ; Systemic antibiotic ocular medication within last month ; Contact lenses within last week ; Any medication Day 0 study ( except paracetamol contraceptive ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>